We thankDrDoganandColleaguesfor their commentonourprevi-ously described case [1] and for their contribution on the therapy ofprosthetic valve thrombosis (PVT) during pregnancy [2–4].Wetreatedwiththrombolysisa21year-oldUgandanfemalepatientwith known rheumatic heart disease for highly suspected acute PVT,who had undergone mitral valve replacement with a bileaflet mechan-icalprosthesis(St.Judeno.29)aboutthreemonthsbefore[1].Diagnosiswas based on clinical evaluation and transthoracic echocardiography(TTE).The occurrence of acute PVT was likely due to poor internationalnormalized ratio (INR) control and limited patient's compliance toanticoagulation therapy (warfarin).ItmustbeunderlinedthattheyoungpatientwasnotpregnantatthetimeofacutePVT.Pregnancyoccurredsubsequently,asdescribedinourcase report [1]. The fact that the patient was not pregnant made PVTmanagement easier, particularly the choice to initiate thrombolysis.Furthermore, at that time (May 2011) no urgent prosthetic valve re-placementcouldbeperformedinUganda[5].Thus,theonlymedicalop-tion was thrombolysis. Of further relevance, the patient with highlysuspected PVT was in cardiogenic shock, with evidence of multi-organfailure as demonstrated by anuria and high INR value (INR 9) likely relat-ed to acute liver failure [6]. For this reason, vitamin K was administeredand emergent thrombolysis was performed (standard intravenous bolusof tenecteplase) [7]. With regard to echocardiographic diagnosis, notransesophageal probe was available in the hospital where the patientwastreatedatthetimeoftheevent.Accordingtothe2014AHA/ACCVal-vularHeartDiseaseGuidelinebothTTEandtransesophagealechocardiog-raphy (TEE) are recommended for the evaluation of a suspected PVT(classI, levelofevidence Bforbothapproaches) [7]. However,webelievethat in the setting of hemodynamic instability TEE is not always essentialand should beused with caution. For instance, this is the case of hemo-dynamicallyunstablepatientswithatrialfibrillation(AF)andhighven-tricular response rate [8], where the benefit of immediate electricalcardioversion overwhelms the thromboembolic risk in the absence ofpreliminary TEE screening. Invasive mechanical ventilation and man-agement of cardiogenic shock with inotropic agents and/or mechanicalcirculatory support could potentially allow hemodynamic stabilizationof the patient, thus permitting further investigations such as TEE orfluoroscopy. It is worth underlining how Biteker and Ozkan were ableto manage a hemodynamically unstable patient (blood pressure atpresentation 65/35 mm Hg) and perform TEE, which allowed the iden-tificationofalargeprostheticthrombus(1.6×1cm)[9].Intheirreport-ed case a 40 mm Hg mean diastolic mitral transvalvular gradient andclinical history were highly suggestive of PVT [9]. Referring to ourcase, at less than three months after valve replacement pannus forma-tion seemed less likely than acute thrombosis; on the other hand, nosystemicsignssuggestiveofendocarditiswerepresent,makingthisdif-ferential diagnosis unlikely too. Micro-emboli can cause distal cerebralischemiceventsafteracutethrombolysis,anditispossiblethataslowerinfusion of thrombolytic treatment can reduce this risk as comparedwith a standard administration protocol, although no evidence canfully support a strategy over the other. Particularly in patients in AF(like our patient was), TEE demonstration of thrombus in the left atrialappendage would add information about a potential risk of embolicevents; nevertheless, thrombus identification in the appendage in thereportedoccasionwould havenot substantiallymodi fiedourtherapeu-tic strategy.Finally, TEE-guided low-dose, slow infusion of tissue-type plas-minogen activator with repeateddoses have been demonstrated asasafeandsuccessfulstrategybyOzkanetal.[2,3]. We personallyhave no direct experience on thrombolysis in PVT in pregnancy. Itappears reasonable that thefinal decision on the best approach–surgery versus thrombolysis– be related to the experience of the
Read full abstract